New York State Common Retirement Fund’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,657
| Closed | -$700K | – | 3431 |
|
|
2024
Q1 | $700K | Buy |
17,657
+2,782
| +19% | +$82.1K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $284K | Buy |
14,875
+5,241
| +54% | +$72.8K | ﹤0.01% | 2316 |
|
|
2023
Q3 | $110K | Buy |
9,634
+4,155
| +76% | +$51.1K | ﹤0.01% | 2668 |
|
|
2023
Q2 | $56.3K | Sell |
5,479
-26
| -0.5% | -$234 | ﹤0.01% | 3111 |
|
|
2023
Q1 | $42.5K | Buy |
5,505
+68
| +1% | +$542 | ﹤0.01% | 3022 |
|
|
2022
Q4 | $40K | Hold |
5,437
| – | – | ﹤0.01% | 3120 |
|
|
2022
Q3 | $39K | Buy |
5,437
+40
| +0.7% | +$330 | ﹤0.01% | 3172 |
|
|
2022
Q2 | $46K | Hold |
5,397
| – | – | ﹤0.01% | 3221 |
|
|
2022
Q1 | $48K | Hold |
5,397
| – | – | ﹤0.01% | 3178 |
|
|
2021
Q4 | $75K | Sell |
5,397
-20
| -0.4% | -$248 | ﹤0.01% | 3148 |
|
|
2021
Q3 | $58K | Sell |
5,417
-4,883
| -47% | -$45K | ﹤0.01% | 3227 |
|
|
2021
Q2 | $93K | Buy |
+10,300
| New | +$112K | ﹤0.01% | 3220 |
|
|
2017
Q1 | – | Sell |
-1,787
| Closed | -$16K | – | 3159 |
|
|
2016
Q4 | $16K | Hold |
1,787
| – | – | ﹤0.01% | 3106 |
|
|
2016
Q3 | $58K | Hold |
1,787
| – | – | ﹤0.01% | 3072 |
|
|
2016
Q2 | $33K | Sell |
1,787
-1,300
| -42% | -$23.1K | ﹤0.01% | 3109 |
|
|
2016
Q1 | $51K | Hold |
3,087
| – | – | ﹤0.01% | 3060 |
|
|
2015
Q4 | $96K | Buy |
+3,087
| New | +$105K | ﹤0.01% | 3018 |
|
|
2015
Q3 | – | Sell |
-396
| Closed | -$24K | – | 3211 |
|
|
2015
Q2 | $24K | Buy |
+396
| New | +$23.6K | ﹤0.01% | 3267 |
|
New York State Common Retirement Fund's ALPN Position: Q2 2024 in Review
New York State Common Retirement Fund sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 17,657 shares — an estimated $700K sold.
New York State Common Retirement Fund first reported a position in ALPN in Q2 2015 and held it in 18 quarters. The position peaked at $700K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- New York State Common Retirement Fund reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- New York State Common Retirement Fund sold 17,657 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $700K.
- New York State Common Retirement Fund first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 18 quarters.
- New York State Common Retirement Fund's Alpine Immune Sciences Inc position peaked at $700K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on New York State Common Retirement Fund's 13F filing for Q2 2024, filed 31 Jul 2024.